Loop Capital analyst Mark Schappel downgrades Weave Communications (NYSE:WEAV) from Buy to Hold.
Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target
Shares of Incyte Corporation (NASDAQ: INCY) recovered last week, after having been under pressure on setbacks to its LIMBER Program.
